Human genetic polymorphisms in metabolic activation and detoxification pathways are a major source of inter-individual variation in susceptibility to cancer. We have developed sensitive DNA-based genotyping assays for detecting the at-risk genetic variants for enzymes that protect against carcinogens in cigarette smoke, diet, industrial processes and environmental pollution. Following testing of over 1000 individuals for these candidate susceptibility genes, we find that the frequency of the at-risk genotypes for glutathione transferase mu (GSTM1), n-acetyltransferase (NAT1 and NAT2) and aryl hydrocarbon hydroxylase (CYP1A1) vary significantly between Asians, Caucasian- and African-americans. Such variation suggests the possibility that some of the ethnic differences in cancer incidence may be due to genetic differences as well as exposure differences. In addition, we have genotyped ~1000 individuals in control and carcinogen-exposed populations and find that individuals with at-risk genotypes have higher levels of genotoxic damage (DNA adducts, HPRT mutation frequency, chromosome damage) in lymphocytes. Analysis of HPRT mutation frequency in smokers indicates that years of smoking, as well as current smoking, influences mutation damage. In collaboration with Jack Taylor, NIEHS we are testing the impact of these candidate cancer susceptibility genes in studies of bladder cancer, lung cancer and liver cancer. Individuals that carry the at-risk genotype for glutathione transferase mu, which detoxifies constituents of cigarette smoke, suffer a 70% increased risk of bladder cancer (p=0.004). In ongoing studies with researchers at the National Cancer Institute, Columbia University, University of North Carolina and University of Keele, England we are exploring how genetic variability in carcinogen metabolism affects risk for cancer of the bladder, lung, liver, gastric, colon, head and neck. These studies seek to integrate environmental and genetic factors in the development of human disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES046008-04
Application #
3755430
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Levings, Daniel C; Wang, Xuting; Kohlhase, Derek et al. (2018) A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations. Redox Biol 19:235-249
Reynolds, Lindsay M; Lohman, Kurt; Pittman, Gary S et al. (2017) Tobacco exposure-related alterations in DNA methylation and gene expression in human monocytes: the Multi-Ethnic Study of Atherosclerosis (MESA). Epigenetics 12:1092-1100
Stracquadanio, Giovanni; Wang, Xuting; Wallace, Marsha D et al. (2016) The importance of p53 pathway genetics in inherited and somatic cancer genomes. Nat Rev Cancer 16:251-65
Wang, Xuting; Campbell, Michelle R; Lacher, Sarah E et al. (2016) A Polymorphic Antioxidant Response Element Links NRF2/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders. Cell Rep 15:830-842
Reynolds, Lindsay M; Wan, Ma; Ding, Jingzhong et al. (2015) DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis. Circ Cardiovasc Genet 8:707-16
Joubert, Bonnie R; HÃ¥berg, Siri E; Bell, Douglas A et al. (2014) Maternal smoking and DNA methylation in newborns: in utero effect or epigenetic inheritance? Cancer Epidemiol Biomarkers Prev 23:1007-17
Zeron-Medina, Jorge; Wang, Xuting; Repapi, Emmanouela et al. (2013) A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection. Cell 155:410-22
Yuan, Jian-Min; Chan, Kenneth K; Coetzee, Gerhard A et al. (2008) Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis 29:1386-93
Visvanathan, Kala; Crum, Rosa M; Strickland, Paul T et al. (2007) Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcohol Clin Exp Res 31:467-76

Showing the most recent 10 out of 42 publications